G

Geneos Therapeutics

14 employees

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Immunotherapy
Genomics
Therapeutics
Machine Learning and AI
Pharmaceutical

Date founded

2016

Funding rounds raised

Total raised

$17M

from 11 investors over 11 rounds

G

Geneos Therapeutics raised $5M on April 12, 2023

Investors: 3B Future Health Fund

G

Geneos Therapeutics raised $17M on March 24, 2022

Investors: Korea Investment Partners, -, Inovio Pharmaceuticals Inc., Flerie Invest and Global Bio Fund

G

Geneos Therapeutics raised $12M on March 3, 2021

Investors: Korea Investment Partners, Inovio Pharmaceuticals Inc. and -

G

Geneos Therapeutics raised $11M on February 21, 2019

Investors: Inovio Pharmaceuticals Inc. and -

FAQ